Open access
Jul 2026
In silico identification of novel PTP1B inhibitors by the investigation of molecular mechanism, QSAR, and DFT studies
Overall, the synergy of the computational methods has made CID 44560744 a lead scaffold for the development and optimization of selective PTP1B inhibitors for T2DM therapy.
Humaira Zulfiqar, Samira Akter, J. Tasnim et al.
· In Silico Pharmacology · 1 citation